Attenuated α-adrenoceptor-mediated arterial and venous constrictions in rat models of diabetes

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 128-133

  Leung, Joanne Y T ^a   Kwok, Evelyn W Y ^a   Liu, G Y ^b   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

High fructose diet; Mean circulatory filling pressure; Noradrenaline; Type 2 diabetes; Vasoconstriction

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; FRUCTOSE; INSULIN; NORADRENALIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE DIET; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISEASE MODEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VEIN TONE; VENOCONSTRICTION; ANIMAL; ARTERY; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; HYPERINSULINISM; METABOLISM; PATHOPHYSIOLOGY; VASOCONSTRICTION; VEIN; WISTAR RAT;

ANIMALS; ARTERIES; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FRUCTOSE; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; TRIGLYCERIDES; VASOCONSTRICTION; VEINS;

EID: 77954624657     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.009     Document Type: Article

References (44)

1. Bieger W.P., Michel G., Barwich D., Biehl K., Wirth A. Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism 1984, 33:982-987.
2. Blondel O., Bailbe D., Portha B. In vivo insulin resistance in streptozotocin-diabetic rats - evidence for reversal following oral vanadate treatment. Diabetologia 1989, 32:185-190.
3. Briefel R.R., Johnson C.L. Secular trends in dietary intake in the United States. Annu. Rev. Nutr. 2004, 24:401-431.
4. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
5. Carlson S.H., Shelton J., White C.R., Wyss J.M. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 2000, 35:403-408.
6. Cheng X., Pang C.C. Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 2004, 484:263-268.
7. Cheng X., Leung S.W., Lim S.L., Pang C.C. Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 2003, 458:299-304.
8. D'Angelo G., Elmarakby A.A., Pollock D.M., Stepp D.W. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 2005, 46:806-811.
9. de Moura R.F., Ribeiro C., de Oliveira J.A., Stevanato E., de Mello M.A. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br. J. Nutr. 2009, 101:1178-1184.
10. Deng S., Vatamaniuk M., Huang X., Doliba N., Lian M.M., Frank A., Velidedeoglu E., Desai N.M., Koeberlein B., Wolf B., Barker C.F., Naji A., Matschinsky F.M., Markmann J.F. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004, 53:624-632.
11. Dincer U.D., Bidasee K.R., Guner S., Tay A., Ozcelikay A.T., Altan V.M. The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes 2001, 50:455-461.
12. Donath M.Y., Gross D.J., Cerasi E., Kaiser N. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999, 48:738-744.
13. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 2002, 76:911-922.
14. Gaesser G.A. Carbohydrate quantity and quality in relation to body mass index. J. Am. Diet. Assoc. 2007, 107:1768-1780.
15. Giacchetti G., Sechi L.A., Griffin C.A., Don B.R., Mantero F., Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J. Hypertens. 2000, 18:695-702.
16. Gumbiner B., Mucha J.F., Lindstrom J.E., Rekhi I., Livingston J.N. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation. Am. J. Physiol. 1996, 270:E424-E429.
17. Guyton A.C. Venous return. Handbook of Physiology 1963, vol. II:1099-1133. American Physiological Society, Washington, DC. W.F. Hamilton, P. Dow (Eds.).
18. Hebden R.A., Bennett T., Gardiner S.M. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats. Am. J. Physiol. 1987, 253:R726-R734.
19. Hicks K.K., Seifen E., Stimers J.R., Kennedy R.H. Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control. J. Auton. Nerv. Syst. 1998, 69:21-30.
20. Huang B.W., Chiang M.T., Yao H.T., Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diab. Obes. Metab. 2004, 6:120-126.
21. Hutchings S.R., Song D., Fricker S.P., Pang C.C. The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 2005, 528:132-136.
22. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
23. Jackson C.V., Carrier G.O. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J. Cardiovasc. Pharmacol. 1983, 5:260-265.
24. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003, 46:3-19.
25. Knowles N.G., Landchild M.A., Fujimoto W.Y., Kahn S.E. Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Diab. Care 2002, 25:292-297.
26. Kotchen T.A., Reddy S., Zhang H.Y. Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat. Am. J. Hypertens. 1997, 10:1020-1026.
27. Le K.A., Tappy L. Metabolic effects of fructose. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:469-475.
28. Marchetti P., Del Guerra S., Marselli L., Lupi R., Masini M., Pollera M., Bugliani M., Boggi U., Vistoli F., Mosca F., Del Prato S. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J. Clin. Endocrinol. Metab. 2004, 89:5535-5541.
29. Mathis D., Vence L., Benoist C. Beta-Cell death during progression to diabetes. Nature 2001, 414:792-798.
30. Matthews D.R., Cull C.A., Stratton I.M., Holman R.R., Turner R.C. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet. Med. 1998, 15:297-303.
31. Oron-Herman M., Kamari Y., Grossman E., Yeger G., Peleg E., Shabtay Z., Shamiss A., Sharabi Y. Metabolic syndrome: comparison of the two commonly used animal models. Am. J. Hypertens. 2008, 21:1018-1022.
32. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
33. Pang C.C. Measurement of body venous tone. J. Pharmacol. Toxicol. Meth. 2000, 44:341-360.
34. Park O.J., Cesar D., Faix D., Wu K., Shackleton C.H., Hellerstein M.K. Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem. J. 1992, Pt 3:753-757.
35. Rossetti L. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin. Invest. Med. 1995, 18:255-260.
36. Shafrir E., Ziv E., Kalman R. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J. 2006, 47:212-224.
37. Song D., Hutchings S., Pang C.C. Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur. J. Pharmacol. 2005, 508:205-210.
38. Stevens M.J., Raffel D.M., Allman K.C., Dayanikli F., Ficaro E., Sandford T., Wieland D.M., Pfeifer M.A., Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998, 98:961-968.
39. Thorburn A.W., Storlien L.H., Jenkins A.B., Khouri S., Kraegen E.W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr. 1989, 49:1155-1163.
40. van Gurp P.J., Willemsen J.J., Lenders J.W., Ross H.A., Sweep C.G., Smits P., Tack C.J. Forearm vasoconstrictor response in uncomplicated type 1 diabetes mellitus. Eur. J. Clin. Invest. 2006, 36:674-681.
41. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 1999, 104:787-794.
42. Yamamoto J., Trippodo N.C., Ishise S., Frohlich E.D. Total vascular pressure-volume relationship in the conscious rat. Am. J. Physiol. 1980, 238:H823-H828.
43. Youn J.H., Kim J.K., Buchanan T.A. Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection. Diabetes 1994, 43:564-571.
44. Yu Z., McNeill J.H. Blood pressure and heart rate response to vasoactive agents in conscious diabetic rats. Can. J. Physiol. Pharmacol. 1992, 70:1542-1548.